DigiPath Labs Featured on Leading Cannabis YouTube Channel


Ryan Allway

March 24th, 2016

News, Top News


DigiPath Inc. (OTCQB: DIGP), a leading provider of cannabis testing services through its DigiPath Labs subsidiary, recently announced that CEO Todd Denkin was interviewed on GFarmaTV – a leading YouTube channel covering the news, products, and lifestyleof the cannabis industry. In the video, Mr. Denkin provides GFarmaTV with a tour of its Las Vegas facility and explains how it partners with growers to test cannabis in batches.

According to GreenWave Advisors, the cannabis testing industry is expected to reach $850 million in size by 2020. The cannabis research firm also noted that cannabis testing services are the most attractive subsets of the cannabis industry, with the potential to expand its top- and bottom-line results through ancillary analytics and consulting services on top of bread-and-butter lab analysis services.

Read the entire press release here:

DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCQB: DIGP), was recently featured on GFarmaTV, a YouTube channel that covers the news, products, and lifestyle of the cannabis industry. In the video, DigiPath, Inc., CEO Todd Denkin offers an inside look at the cutting-edge cannabis testing facility in Las Vegas.

“It was exciting to have the GFarmaTV crew tour the DigiPath Labs facility,” says Denkin. “We put a lot of work into designing a state-of-the-art cannabis testing lab that provides reliable results, and it’s fun to let our patients, growers, and anyone who’s curious take a look at how we operate.”

In the video, Denkin explains how DigiPath Labs partners with growers to test medicinal cannabis in five-pound batches. He explains that the technicians perform a visual inspection and test for moisture, cannabinoid and terpenoid profiles, heavy metals, pesticides, and microbiological contamination. He also notes that DigiPath Labs tests oils, concentrates, shatters, and edibles.

The video also shows an increasingly popular DigiPath Labs offering: chemo profiling. This DNA testing method creates a digital representation of a particular strain, giving growers a way to distinguish and protect their specialized strains.

“Patents don’t work and trademarks don’t work for marijuana,” Denkin explains in the video, “but chemo profiling does work. So it is a good way to protect your strain simply by giving it a digital stamp, on a server, with a time and the exact profile.”

To view the DigiPath Labs GFarmaTV episode, visit https://www.youtube.com/watch?v=73Fc0wL2I_8&feature=youtu.be.

To learn more about DigiPath Labs, visit www.digipathlabs.com.

 About DigiPath, Inc.

DigiPath, Inc., supports the cannabis industry’s best practices for reliable testing and  education, and brings unbiased cannabis news coverage to the nation. DigiPath’s two business units are DigiPath Labs and TNM News Corp.

For more information, go to www.digipath.com.

Information about Forward-Looking Statements

This press release contains “forward-looking statements” that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s need for additional funding, governmental regulation of the cannabis industry, the demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:
DigiPath, Inc.
Investor Relations
702.470.2249
info@digipath.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading